These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 6324550)

  • 1. Effects of nomifensine on dopaminergic transmission in healthy volunteers evaluated by means of the electroretinographic technique.
    Fornaro P; Dell'Osso L; Perossini M; Placidi GF; Castrogiovanni P
    Acta Neurol (Napoli); 1984 Feb; 6(1):5-10. PubMed ID: 6324550
    [No Abstract]   [Full Text] [Related]  

  • 2. Dopaminergic properties of nomifensine.
    Gianutsos G; Morrow G; Light S; Sweeney MJ
    Pharmacol Biochem Behav; 1982 Nov; 17(5):951-4. PubMed ID: 6294689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cortisol secretion following nomifensine administration in normal subjects.
    Alagna S; Masala A
    Biomedicine; 1979 Nov; 31(7):189-91. PubMed ID: 526541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on brain metabolism of biogenic amines.
    Schacht U; Leven M; Bäcker G
    Br J Clin Pharmacol; 1977; 4Suppl 2(Suppl 2):77S-87S. PubMed ID: 199222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biochemical effects of nomifensine on catecholaminergic systems: in vivo studies.
    Algeri S; Ponzio F; Achilli G; Perego C
    Adv Biochem Psychopharmacol; 1982; 31():219-28. PubMed ID: 7080897
    [No Abstract]   [Full Text] [Related]  

  • 6. Prolactin-lowering effect of nomifensine in the rat.
    Cocchi D; Locatelli V; Picciolini E; Genazzani AR; Müller EE
    Proc Soc Exp Biol Med; 1979 Oct; 162(1):38-43. PubMed ID: 228312
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effects of retinal intrinsic dopamine on the in in vivo electroretinogram of rabbits].
    Kobayashi A; Shirao Y; Tagawa S; Katoh K; Tamura T
    Nippon Ganka Gakkai Zasshi; 1996 Feb; 100(2):111-7. PubMed ID: 8851149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diclofensine (Ro 8-4650)--a potent inhibitor of monoamine uptake: biochemical and behavioural effects in comparison with nomifensine.
    Keller HH; Schaffner R; Carruba MO; Burkard WP; Pieri M; Bonetti EP; Scherschlicht R; Da Prada M; Haefely WE
    Adv Biochem Psychopharmacol; 1982; 31():249-63. PubMed ID: 6979165
    [No Abstract]   [Full Text] [Related]  

  • 9. [Acute effects of nomifensine on brain levels of NE and DA in rats].
    Ravizza L; Torre E; Bogetto F; Rebaudengo P
    Minerva Psichiatr; 1980; 21(1):45-7. PubMed ID: 7464482
    [No Abstract]   [Full Text] [Related]  

  • 10. Chronic treatment with a dopamine uptake blocker changes dopamine and acetylcholine but not glutamate and GABA concentrations in prefrontal cortex, striatum and nucleus accumbens of the awake rat.
    Hernández LF; Segovia G; Mora F
    Neurochem Int; 2008 Feb; 52(3):457-69. PubMed ID: 17881090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacodynamics of nomifensine: a review of studies in healthy subjects.
    Siegfried K; Taeuber K
    J Clin Psychiatry; 1984 Apr; 45(4 Pt 2):33-8. PubMed ID: 6370972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in dopamine and acetylcholine in striatum of the awake rat after chronic treatment with a dopamine uptake blocker.
    Hernández LF; Segovia G; Mora F
    Brain Res Bull; 2006 Feb; 68(6):448-52. PubMed ID: 16459201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cerebral NE and DA levels after chronic treatment with nomifensine].
    Ravizza L; Bogetto F; Torre E; Rebaudengo P
    Minerva Psichiatr; 1980; 21(1):55-6. PubMed ID: 7464484
    [No Abstract]   [Full Text] [Related]  

  • 14. Pharmacology of nomifensine: a review of animal studies.
    Fielding S; Szewczak MR
    J Clin Psychiatry; 1984 Apr; 45(4 Pt 2):12-20. PubMed ID: 6370970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma nomifensine concentration. Cardiological effects and clinical response.
    McIntyre IM; Burrows GD; Norman TR; Dumovic P; Vohra J
    Int Pharmacopsychiatry; 1980; 15(6):325-33. PubMed ID: 7298263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of the pharmacodynamic profiles of nomifensine and amitriptyline in normal subjects.
    Chan MY; Ehsanullah R; Wadsworth J; McEwen J
    Br J Clin Pharmacol; 1980 Mar; 9(3):247-53. PubMed ID: 7362734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopaminergic involvement in the hyperalgesic effect of nomifensine.
    Gonzalez JP; Sewell RD; Spencer PS
    Life Sci; 1981 Feb; 28(8):951-6. PubMed ID: 7219061
    [No Abstract]   [Full Text] [Related]  

  • 18. [Glycemia and insulinemia after oral administration of Nomifensine].
    Morosini PP; Testa I; Ferretti GF; Campanella N; Governatori D
    Boll Soc Ital Biol Sper; 1980 Mar; 56(6):537-41. PubMed ID: 6990942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sex differences in methamphetamine-evoked striatal dopamine of mice are reversed by nomifensine.
    Kunnathur V; Shemisa K; Liu B; Salvaterra TJ; Dluzen DE
    Neurotoxicol Teratol; 2006; 28(5):557-62. PubMed ID: 16978834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of nomifensine and desipramine on tyramine pressor responses in healthy volunteers.
    McEwen J
    Br J Clin Pharmacol; 1977; 4Suppl 2(Suppl 2):157S-158S. PubMed ID: 911649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.